These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 33101075)
21. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers. Sher L; Oquendo MA; Burke AK; Cooper TB; Mann JJ J Affect Disord; 2013 Dec; 151(3):1108-12. PubMed ID: 23866302 [TBL] [Abstract][Full Text] [Related]
22. Dopaminergic-like activity in toxic fescue alters prolactin but not growth hormone or thyroid stimulating hormone in ewes. Elsasser TH; Bolt DJ Domest Anim Endocrinol; 1987 Oct; 4(4):259-69. PubMed ID: 3507894 [TBL] [Abstract][Full Text] [Related]
23. [The relationship between TSH response to TRH and GH response to dopaminergic agents in patients with acromegaly]. Tokuyama T; Yoshinari M; Okamura K; Ikenoue H; Sato K; Kuroda T; Fujishima M Nihon Naibunpi Gakkai Zasshi; 1991 Feb; 67(2):65-74. PubMed ID: 1674920 [TBL] [Abstract][Full Text] [Related]
25. The dexamethasone suppression test and thyroid stimulating hormone response to TRH in RDC schizoaffective patients. Sauer H; Koehler KG; Sass H; Hornstein C; Minne HW Eur Arch Psychiatry Neurol Sci; 1984; 234(4):264-7. PubMed ID: 6441714 [TBL] [Abstract][Full Text] [Related]
26. Neuroendocrine Assessment of Dopaminergic Function during Antidepressant Treatment in Major Depressed Patients. Duval F; Mokrani MC; Erb A; Gonzalez Lopera F; Danila V; Tomsa M Brain Sci; 2021 Mar; 11(4):. PubMed ID: 33810562 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of the hypothalamic-pituitary-adrenal axis in untreated patients with polymyalgia rheumatica and healthy controls. Demir H; Tanriverdi F; Ozoğul N; Caliş M; Kirnap M; Durak AC; Keleştimur F Scand J Rheumatol; 2006; 35(3):217-23. PubMed ID: 16766369 [TBL] [Abstract][Full Text] [Related]
28. Nocturnal secretion of TSH and ACTH in male patients with depression and healthy controls. Peteranderl C; Antonijevic IA; Steiger A; Murck H; Held K; Frieboes RM; Uhr M; Schaaf L J Psychiatr Res; 2002; 36(3):189-96. PubMed ID: 11886697 [TBL] [Abstract][Full Text] [Related]
29. Prolactin response to thyrotropin-releasing hormone in schizoaffective depressed compared to depressed and schizophrenic men and healthy controls. Wahby VS; Ibrahim GA; LeeChuy I; Saddik FW; Giller EL; Mason JW Schizophr Res; 1990; 3(5-6):277-81. PubMed ID: 2126454 [TBL] [Abstract][Full Text] [Related]
30. Effect of galanin on basal and stimulated secretion of prolactin, gonadotropins, thyrotropin, adrenocorticotropin and cortisol in humans. Arvat E; Gianotti L; Ramunni J; Grottoli S; Brossa PC; Bertagna A; Camanni F; Ghigo E Eur J Endocrinol; 1995 Sep; 133(3):300-4. PubMed ID: 7581945 [TBL] [Abstract][Full Text] [Related]
31. Catecholamine and HPA axis dysfunction in depression: relationship with suicidal behavior. Pitchot W; Reggers J; Pinto E; Hansenne M; Ansseau M Neuropsychobiology; 2003; 47(3):152-7. PubMed ID: 12759559 [TBL] [Abstract][Full Text] [Related]
33. Associations among dexamethasone non-suppression and TRH-induced hormonal responses: increased specificity for melancholia? Banki CM; Arato M; Papp Z; Rihmer Z; Kovacs Z Psychoneuroendocrinology; 1986; 11(2):205-11. PubMed ID: 3092267 [TBL] [Abstract][Full Text] [Related]
34. Melatonin, cortisol and ACTH in patients with major depressive disorder and healthy humans with special reference to the outcome of the dexamethasone suppression test. Beck-Friis J; Ljunggren JG; Thorén M; von Rosen D; Kjellman BF; Wetterberg L Psychoneuroendocrinology; 1985; 10(2):173-86. PubMed ID: 2994141 [TBL] [Abstract][Full Text] [Related]
35. Neuroendocrine profile of SDZ HDC-912 and OPC-4392, two new atypical antipsychotic drugs, in schizophrenic patients. Duval F; Mokrani MC; Macher JP; Crocq MA; Castro JO; Bailey P; Lataste X Psychopharmacology (Berl); 1993; 110(1-2):177-80. PubMed ID: 7870880 [TBL] [Abstract][Full Text] [Related]
36. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness. Van den Berghe G; de Zegher F; Bowers CY; Wouters P; Muller P; Soetens F; Vlasselaers D; Schetz M; Verwaest C; Lauwers P; Bouillon R Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573 [TBL] [Abstract][Full Text] [Related]
37. Hypothalamic-pituitary-end organ function in women with bipolar depression. Rasgon NL; Kenna HA; Wong ML; Whybrow PC; Bauer M Psychoneuroendocrinology; 2007 Apr; 32(3):279-86. PubMed ID: 17317022 [TBL] [Abstract][Full Text] [Related]
38. [Thyrotropin-releasing hormone in psychiatry: marker, predictor and therapeutical tool]. Babinski T; Paunović VR Srp Arh Celok Lek; 1994; 122(11-12):341-3. PubMed ID: 17974414 [TBL] [Abstract][Full Text] [Related]
39. The stress system in the human brain in depression and neurodegeneration. Swaab DF; Bao AM; Lucassen PJ Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533 [TBL] [Abstract][Full Text] [Related]
40. The combined T3/TRH test in depressed patients and healthy controls. Schüle C; Baghai TC; Tsikolata V; Zwanzger P; Eser D; Schaaf L; Rupprecht R Psychoneuroendocrinology; 2005 May; 30(4):341-56. PubMed ID: 15694114 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]